We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$266M
AUM Growth
+$61.1M
Cap. Flow
+$48.5M
Cap. Flow %
18.26%
Top 10 Hldgs %
97.49%
Holding
26
New
2
Increased
7
Reduced
1
Closed
4
Avg Time Held
1.6 quarters
Top 10 Avg Time Held
1.1 quarters
Top 20 Avg Time Held
1.6 quarters

Top Buys

Rank Stock Value
1
NEO icon
NeoGenomics
NEO
+$31.1M
2
TMO icon
Thermo Fisher Scientific
TMO
+$20.7M
3
NTRA icon
Natera
NTRA
+$13.2M
4
TECH icon
Bio-Techne
TECH
+$12.9M
5
GH icon
Guardant Health
GH
+$6.09M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$22M
2
ADPT icon
Adaptive Biotechnologies
ADPT
+$10.1M
3
CELL
PhenomeX Inc. Common Stock
CELL
+$8.24M
4
A icon
Agilent Technologies
A
+$2.66M
5
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
+$18.6K

Sector Composition

Rank Sector Weight
1 Healthcare 83.88%
2 Materials 13.66%
3 Technology 1%
4 Financials 0.51%
5 Communication Services 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NTRA icon
1
Natera
NTRA
$59.1B
$52M 19.56%
457,981
+129,145
+39% +$13.2M
2020 Q4
2 quarters
CDNA icon
2
CareDx
CDNA
$3.47B
$47.6M 17.93%
520,516
+29,000
+6% +$2.31M
2020 Q4
2 quarters
AMRS
3
DELISTED
Amyris Inc.
AMRS
$36.3M 13.66%
2,217,216
+125,000
+6% +$1.86M
2020 Q4
2 quarters
TMO icon
4
Thermo Fisher Scientific
TMO
$242B
$31.8M 11.96%
63,000
+43,867
+229% +$20.7M
2020 Q4
2 quarters
NEO icon
5
NeoGenomics
NEO
$2.37B
$31.7M 11.94%
+702,222
New +$31.1M
2021 Q2
0 quarters
GH icon
6
Guardant Health
GH
$23.9B
$28.6M 10.78%
230,595
+45,265
+24% +$6.09M
2020 Q4
2 quarters
ILMN icon
7
Illumina
ILMN
$41.2B
$15.7M 5.9%
34,063
+3,840
+13% +$1.55M
2020 Q4
2 quarters
TECH icon
8
Bio-Techne
TECH
$11.4B
$13.8M 5.18%
+122,204
New +$12.9M
2021 Q2
0 quarters
HTGM
9
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$841K 0.32%
12,073
-343
-3% -$18.6K
2021 Q1
1 quarter
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.2T
$745K 0.28%
6,100
– –
2020 Q4
2 quarters
MSFT icon
11
Microsoft
MSFT
$3.84T
$738K 0.28%
2,726
– –
2020 Q4
2 quarters
NVDA icon
12
NVIDIA
NVDA
$5.65T
$726K 0.27%
36,280
– –
2020 Q4
2 quarters
AMZN icon
13
Amazon
AMZN
$2.71T
$688K 0.26%
4,000
– –
2020 Q4
2 quarters
ADBE icon
14
Adobe
ADBE
$94.5B
$641K 0.24%
1,094
– –
2020 Q4
2 quarters
PHYS icon
15
Sprott Physical Gold
PHYS
$14.8B
$640K 0.24%
45,626
– –
2020 Q4
2 quarters
JPM icon
16
JPMorgan Chase
JPM
$884B
$613K 0.23%
13,762
+12,000
+681% +$1.88M
2021 Q1
1 quarter
AAPL icon
17
Apple
AAPL
$4.87T
$548K 0.21%
4,000
– –
2020 Q4
2 quarters
SYK icon
18
Stryker
SYK
$106B
$468K 0.18%
1,800
– –
2020 Q4
2 quarters
CVX icon
19
Chevron
CVX
$405B
$463K 0.17%
4,420
– –
2021 Q1
1 quarter
V icon
20
Visa
V
$677B
$423K 0.16%
1,809
– –
2020 Q4
2 quarters
ISRG icon
21
Intuitive Surgical
ISRG
$138B
$405K 0.15%
1,320
– –
2020 Q4
2 quarters
GS icon
22
Goldman Sachs
GS
$263B
$316K 0.12%
833
– –
2021 Q1
1 quarter
A icon
23
Agilent Technologies
A
$47.3B
– –
-20,938
Closed -$2.66M –
ADPT icon
24
Adaptive Biotechnologies
ADPT
$4.52B
– –
-251,695
Closed -$10.1M –
EXAS
25
DELISTED
Exact Sciences
EXAS
– –
-166,957
Closed -$22M –
1
2

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Blue Water Life Science Advisors held 26 positions worth $266M, up 30% from $205M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Blue Water Life Science Advisors deployed $48.5M of net new capital in Q2 2021, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was NeoGenomics: 702,222 shares worth $31.7M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 78% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was HTG Molecular Diagnostics, Inc. Common Stock, an estimated $18.6K trimmed.

  • Blue Water Life Science Advisors's largest Q2 2021 buy was NeoGenomics: 702,222 shares worth $31.7M.
  • Blue Water Life Science Advisors added most to Thermo Fisher Scientific in Q2 2021, an estimated $20.7M increase.
  • Blue Water Life Science Advisors's biggest Q2 2021 reduction was HTG Molecular Diagnostics, Inc. Common Stock, cutting an estimated $18.6K.
  • Blue Water Life Science Advisors fully exited Exact Sciences in Q2 2021, selling an estimated $22M.
  • Blue Water Life Science Advisors's ten largest holdings make up 97% of its $266M portfolio in Q2 2021.
  • Blue Water Life Science Advisors opened 2 new positions and closed 4 in Q2 2021.
  • Blue Water Life Science Advisors's portfolio value rose 30% quarter-over-quarter to $266M.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.